Tacalyx
Berlin, Germany · tacalyx.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Tacalyx GmbH develops anticancer therapeutics targeting tumor-associated carbohydrate antigens (TACAs). It is based in Berlin, Germany, and was founded in 2019 as a spin-out of the Max-Planck-Institute of Colloids and Interfaces in Potsdam. The team works on antibody drug development and early pipeline programs.
They take quote requests by email.
What they offer
Antibody generation
Generates antibodies for its TACA-targeting programs.
Cell-based assays
Runs cell-based assays to support development of anticancer therapeutics.
Antibody and protein biochemistry
Performs antibody and protein biochemistry work for therapeutic development.
Glycobiology
Studies glycobiology in support of TACA-targeting oncology research.
What they work on
- Modalities
- Antibody, ADC
- Assays and studies
- cell-based assays
- Therapeutic areas
- cancer
- Sites
- Berlin, Germany · Potsdam, Germany
- Founded
- 2019
Similar labs. Aurora Biolabs, BioAgilytix, Biocopy, Biofidus GmbH
Found in a contract services directory. Listing built from tacalyx.com. Work here? Claim this listing.